Full Text
The Full Text of this article is available as a PDF (28.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Frankel S. Study of the Food and Drug Administration files on Propecia: dosages, side effects, and recommendations. Arch Dermatol. 1999 Mar;135(3):257–258. doi: 10.1001/archderm.135.3.257. [DOI] [PubMed] [Google Scholar]
- Kaufman K. D., Olsen E. A., Whiting D., Savin R., DeVillez R., Bergfeld W., Price V. H., Van Neste D., Roberts J. L., Hordinsky M. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578–589. doi: 10.1016/s0190-9622(98)70007-6. [DOI] [PubMed] [Google Scholar]
- Leyden J., Dunlap F., Miller B., Winters P., Lebwohl M., Hecker D., Kraus S., Baldwin H., Shalita A., Draelos Z. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):930–937. doi: 10.1016/s0190-9622(99)70081-2. [DOI] [PubMed] [Google Scholar]
- Price V. H., Roberts J. L., Hordinsky M., Olsen E. A., Savin R., Bergfeld W., Fiedler V., Lucky A., Whiting D. A., Pappas F. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):768–776. doi: 10.1067/mjd.2000.107953. [DOI] [PubMed] [Google Scholar]
- Price V. H. Treatment of hair loss. N Engl J Med. 1999 Sep 23;341(13):964–973. doi: 10.1056/NEJM199909233411307. [DOI] [PubMed] [Google Scholar]
- Roberts J. L., Fiedler V., Imperato-McGinley J., Whiting D., Olsen E., Shupack J., Stough D., DeVillez R., Rietschel R., Savin R. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol. 1999 Oct;41(4):555–563. [PubMed] [Google Scholar]
